Smoking cessation or reduction with nicotine replacement therapy: a placebo-controlled double blind trial with nicotine gum and inhaler
Open Access
- 27 November 2009
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 9 (1) , 433
Abstract
Even with effective smoking cessation medications, many smokers are unable to abruptly stop using tobacco. This finding has increased interest in smoking reduction as an interim step towards complete cessation.Keywords
This publication has 15 references indexed in Scilit:
- Efficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trialNicotine & Tobacco Research, 2006
- Smoking reduction treatment with 4-mg nicotine gum: A double-blind, randomized, placebo-controlled studyClinical Pharmacology & Therapeutics, 2005
- Effectiveness of the Nicotine Inhaler for Smoking Cessation in an OTC SettingAmerican Journal of Health Behavior, 2004
- Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo‐controlled trial of nicotine gum with 2‐year follow‐upAddiction, 2003
- Effect of smoking reduction on later cessation: A pilot experimental studyNicotine & Tobacco Research, 2003
- Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: A reviewNicotine & Tobacco Research, 2002
- Nicotine Replacement to Reduce Cigarette Consumption in Smokers Who Are Unwilling to Quit: A Randomized TrialJournal of Clinical Psychopharmacology, 2002
- Individual differences in preferences for and responses to four nicotine replacement productsPsychopharmacology, 2001
- Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhalerNicotine & Tobacco Research, 2000
- Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safetyBMJ, 2000